HUTCHMED (China) Limited
HCM
$12.20
$0.040.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 549.12M | 548.82M | 548.51M | 575.35M | 602.20M |
| Total Other Revenue | -- | -- | -- | -68.52M | -137.04M |
| Total Revenue | 549.12M | 548.82M | 548.51M | 575.35M | 602.20M |
| Cost of Revenue | 548.01M | 552.32M | 556.63M | 588.53M | 620.43M |
| Gross Profit | 1.11M | -3.50M | -8.12M | -13.18M | -18.23M |
| SG&A Expenses | 107.88M | 105.45M | 103.03M | 99.88M | 96.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 583.90M | 585.79M | 587.67M | 604.78M | 621.90M |
| Operating Income | -34.78M | -36.97M | -39.16M | -29.43M | -19.70M |
| Income Before Tax | 20.08M | 270.71M | 521.34M | 528.19M | 535.03M |
| Income Tax Expenses | 1.66M | 32.63M | 63.61M | 65.54M | 67.47M |
| Earnings from Continuing Operations | 18.42 | 238.08 | 457.73 | 462.65 | 467.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -536.00K | -679.50K | -823.00K | -750.50K | -678.00K |
| Net Income | 17.88M | 237.40M | 456.91M | 461.90M | 466.88M |
| EBIT | -34.78M | -36.97M | -39.16M | -29.43M | -19.70M |
| EBITDA | -20.52M | -23.18M | -25.85M | -16.67M | -7.49M |
| EPS Basic | 0.02 | 0.28 | 0.53 | 0.54 | 0.54 |
| Normalized Basic EPS | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 |
| EPS Diluted | 0.02 | 0.27 | 0.52 | 0.53 | 0.53 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.03 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 3.45B | 3.44B | 3.43B | 3.43B | 3.42B |
| Average Diluted Shares Outstanding | 3.49B | 3.49B | 3.49B | 3.49B | 3.49B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |